Breaking News, Promotions & Moves

Cardinal Health Makes Leadership Changes

Jason Hollar to succeed current Chief Executive Officer, Mike Kaufmann.

By: Kristin Brooks

Managing Editor, Contract Pharma

Cardinal Health has appointed Jason Hollar as the company’s next Chief Executive Officer, effective September 1, 2022. Hollar will also join the Board of Directors effective August 11, 2022. Hollar will succeed current Chief Executive Officer, Mike Kaufmann.
 
Hollar, an experienced financial and operating executive, has served as Cardinal Health’s Chief Financial Officer since May 2020, leading financial activities across the enterprise, including financial strategy, capital deployment, treasury, tax, investor relations, risk management, accounting and reporting. During his tenure, he has helped Cardinal Health prioritize investments in growth businesses, strengthened the balance sheet, and returned capital to shareholders. Prior to joining Cardinal Health, Hollar served as Chief Financial Officer and Executive Vice President for Tenneco. 
 
Also, Patricia English will serve as Cardinal Health’s interim Chief Financial Officer, working with Hollar to ensure a smooth transition. English currently serves as Chief Accounting Officer and Senior Vice President of Cardinal Health and previously served as Vice President of accounting in both the pharmaceutical and medical segments. Cardinal Health’s Board will engage an executive search firm to evaluate candidates for the permanent Chief Financial Officer position.
 
“Mike has been a tremendous leader during his tenure at Cardinal Health, helping the company navigate a period of unprecedented challenges, directing strategic investments for growth and innovation, and cultivating an inclusive and vibrant workforce culture. We are grateful for Mike’s many contributions over his more than 30 years of service and wish him the best in his future endeavors,” said Gregory Kenny, Cardinal Health’s Independent Chairman of the Board. “We look forward to leveraging Jason’s broad executive experience and are confident in his ability to lead Cardinal Health on a path to long-term growth.”
 
Hollar said, “I sincerely appreciate the confidence the Board has placed in me to help position the company for future growth. This is a transformational period at Cardinal Health and I am humbled to have the opportunity to lead a business that plays such a vital role in the healthcare ecosystem. I look forward to working closely with Cardinal Health’s talented employees, management team, and Board as we continue to build upon our strong foundation and deliver value to our customers, communities and shareholders.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters